Shire seen having to sweeten $30 billion offer to win Baxalta

ReutersShire seen having to sweeten $30 billion offer to win BaxaltaReutersLONDON Shire Chief Executive Flemming Ornskov will need to dig deeper in his pocket if he wants to win U.S. biotech company Baxalta. The Danish doctor running the London-listed drugmaker from offices in Massachusetts is not taking the easy option with ...CompaniesShire Pharmaceuticals gets off to better startFinancial TimesDaily Deal Roundup: Onex-backed Jeld-Wen ponders $600-million IPOThe Globe and Mail (subscription)Shire's Baxalta bid: Poison pill or antidote?CNBCPhilly.com -Bloombergall 342 news articles »